Stevanato Group(STVN) - 2021 Q4 - Annual Report

Exhibit 99.1 Stevanato Group Reports Record 2021 Revenue of €843.9 million - Establishes Full Year 2022 Guidance - PIOMBINO DESE, Italy – March 8, 2021 – Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth quarter 2021. For the fourth quarter, revenue increased 12.5% to €232.6 million over last year driven by both seg ...